Pruritus response and skin biomarkers of atopic dermatitis with crisaborole vs. vehicle in patients with mild-to-moderate atopic dermatitis

被引：0
|
作者：
Bissonnette, R. [1 ]
Guttman-Yassky, E. [2 ]
Werth, J. L. [3 ]
Zang, C. [3 ]
Cha, A. [4 ]
Vlahos, B. [3 ]
Myers, D. E. [3 ]
Nocka, K. H. [5 ]
Ports, W. C. [6 ]
机构：
[1] Innovaderm Res, Montreal, PQ, Canada
[2] Icahn Sch Med Mt Sinai, Lab Inflammatory Skin Dis, New York, NY 10029 USA
[3] Pfizer Inc, Collegeville, PA USA
[4] Pfizer Inc, New York, NY USA
[5] Pfizer Inc, Cambridge, MA USA
[6] Pfizer Inc, Groton, CT 06340 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2020年 / 183卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P20
引用
收藏
页码：E104 / E104
页数：1
相关论文
共 50 条
  • [11] EFFICACY OF CRISABOROLE IN PATIENTS WITH MILD-TO-MODERATE ATOPIC DERMATITIS WITH AND WITHOUT COMORBID ALLERGIC RHINITIS
    Spergel, J.
    Blaiss, M.
    Lio, P.
    Kessel, A.
    Takiya, L.
    Werth, J.
    O'Connell, M.
    Zang, C.
    Cork, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S46 - S46
  • [12] Impact of crisaborole in patients with mild-to-moderate atopic dermatitis who received prior treatment
    Gold, Linda Stein
    Shi, Vivian
    Vlahos, Bonnie
    Sanders, Paul
    Zang, Chuanbo
    Cha, Amy
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E118 - E119
  • [13] Efficacy and safety of crisaborole by body region in infants with mild-to-moderate atopic dermatitis
    Schlessinger, Joel
    Shepard, Julie S.
    Forsha, Douglass W.
    Zaenglein, Andrea L.
    Werth, John L.
    Zang, Chuanbo
    Cha, Amy
    Takiya, Liza
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB125 - AB125
  • [14] Efficacy and Safety of Crisaborole by Body Region in Infants with Mild-to-moderate Atopic Dermatitis
    Forsha, Douglass W.
    Schlessinger, Joel
    Shepard, Julie S.
    Werth, John L.
    Zang, Chuanbo
    Cha, Amy
    Takiya, Liza
    PEDIATRICS, 2022, 149 (01)
  • [15] Safety Of Crisaborole In Patients Aged 3 To <24 Months With Mild-To-Moderate Atopic Dermatitis
    Shepard, Julie S.
    Schlessinger, Joel
    Gower, Richard G.
    Su, John C.
    Lynde, Charles
    Cha, Amy
    Graham, Daniela
    Takiya, Liza
    Werth, John L.
    Zang, Chuanbo
    Vlahos, Bonnie
    PEDIATRICS, 2021, 147 (03)
  • [16] Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis with and without comorbid allergies or asthma
    Lio, Peter A.
    Spergel, Jonathan M.
    Cork, Michael J.
    Blaiss, Michael S.
    Kessel, Aharon
    Cantrell, Wendy C.
    Werth, John L.
    O'Connell, Michael A.
    Zang, Chuanbo
    Takiya, Liza
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB97 - AB97
  • [17] Efficacy and Safety of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis With Comorbid Allergic Rhinitis or Asthma
    Spergel, Jonathan
    Blaiss, Michael
    Lio, Peter
    Kessel, Aharon
    Takiya, Liza
    Werth, John
    O'Connell, Michael
    Zang, Chuanbo
    Cork, Michael
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB28 - AB28
  • [18] EFFICACY AND SAFETY OF CRISABOROLE IN PATIENTS ≥3 MONTHS OF AGE WITH MILD-TO-MODERATE ATOPIC DERMATITIS (AD)
    Su, John C.
    Spelman, Lynda J.
    Eichenfield, Lawrence F.
    Gold, Linda F. Stein
    Cha, Amy
    Graham, Daniela
    Takiya, Liza
    Werth, John L.
    Zang, Chuanbo
    Vlahos, Bonnie
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 55 - 56
  • [19] Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis with and without comorbid allergies or asthma
    Lio, P.
    Cork, M. J.
    Blaiss, M. S.
    Kessel, A.
    Cantrell, W. C.
    Werth, J. L.
    O'Connell, M.
    Zang, C.
    Takiya, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E110 - E110
  • [20] Crisaborole Ointment 2%: A Review in Mild to Moderate Atopic Dermatitis
    Sheridan M. Hoy
    American Journal of Clinical Dermatology, 2017, 18 : 837 - 843
12345